Doctor Image

Dr. Ankur Pruthi

Diagnostic Nuclear Medicine


Diagnostic Nuclear Medicine

RGCIRC, Rohini, Delhi - 110 085

About

A sincere, dedicated & dynamic professional with over 15 years’ experience in the field of diagnostic and therapeutic Nuclear Medicine while working in reputed tertiary care / cancer hospitals in New Delhi. Strong background in reporting F-18 FDG, DOTA NOC, PSMA, Fluorodopa, Fluorocholine PET-CT scans and wide variety of Gamma camera scans. Extensive clinical experience in treating patients suffering from thyroid disorders and handling various radionuclide therapies (Iodine-131, Lu-177 therapies, TARE, Bone pain palliation etc.

Specialized Areas

Therapeutic Nuclear Medicine

  • I-131 therapies in treatment of Thyroid cancers and Thyrotoxicosis
  • Lu-177 PSMA and DOTATATE therapies for Prostate cancer and Neuro-endocrine tumours
  • Sm-153 EDTMP therapies for bone pain palliation, Y-90 citrate radiosynovectomy
  • Y-90 Theraspheres and Y-90 SIR spheres therapy for HCC, liver metastases

Educational Background

DNB (Nuclear Medicine), Sir Ganga Ram Hospital, New Delhi: 2014-2016

Diploma in Radiation Medicine (DRM), Radiation Medicine Centre: 2008-2010

MBBS, Pt. B D Sharma PGIMS, Rohtak, Haryana: 2001 – 2007

Experience

  • Consultant, Nuclear Medicine, RGCIRC, Delhi: 2025 – till date
  • Consultant & Head, Manipal Hospital Dwarka, Delhi: 2018- 2025
  • Consultant, Sir Ganga Ram Hospital, New Delhi, Delhi: 2016- 2018
  • Clinical Assistant, RGCIRC, Delhi: 2013-2014
  • Resident, RGCIRC, Delhi: 2010-2013

Professional Journey

Achievements

  • Radiological Safety Officer (Nuclear Medicine) (RSO Level II) certified by AERB, India in 2012
  • Certified “Hospital Radio-pharmacist” by Board of radiation and Isotope Technology (BRIT), India in 2008
  • Certified “Fellow of European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany in 2015
  • Completed 1st Post Graduate Certificate course in “Paediatric Nuclear Medicine” conducted by FMRI, Gurgaon and GOSH, London
  • Certificate in Research Methodology (CRM) by PHFI, Gandhinagar, Gujarat, India
  • “Fellowship” by Singapore Nuclear Medicine Society during Annual conference “Singapore Nuclear Medicine Update 2017” to be held in August 2017
  • Member of National Academy of Medical Sciences, New Delhi, India (MNAMS) in 2018
  • Fellowship awarded by Asian Nuclear Medicine Board (FANMB) during annual conference held in Shanghai, China in May 2019
  • Faculty in many oncology and Nuclear Medicine conferences

Awards

  • “Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
  • “Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
  • Awarded “International Travel Grant” by Department of Science & Technology, Government of India for attending International conference on Radiopharmaceutical Therapy (ICRT), Vietnam in 2010.
  • Oral and poster presentations in many conferences like Nuclear Medicine Update, Singapore; EANM, Germany; ICRT, Vietnam; ICC, BREASTCON & THYROCON.
  • Participated in all major conferences in Nuclear medicine and Oncology conducted by RGCI and other institutions·

Publication

  • Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
  • Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
  • Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
  • Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
  • Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4
  • Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20
  • Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61
  • Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96
  • Gupta N, Pruthi A, Verma R, Manocha A. An unusual case of hyperparathyroidism, presenting as multiple skeletal lesions. World J Nucl Med. 2020 Jan 17;19(2):149-151
  • Seniaray N, Verma R, Khanna S, Belho E, Pruthi A, Mahajan H. Localization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence. Indian J Urol. 2020 Jul-Sep;36(3):191-199.
  • Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva – A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019 Jul-Sep;34(3):209-212.
  • Pruthi A, Kirtani P, Joshi P, Kaur N. Tiger Man Sign-F-18 FDG PET CT Scan Pattern in Muscular and Cutaneous Sarcoidosis: A Case Report and Literature Survey. Indian J Nucl Med. 2020 Jul-Sep;35(3):232-234.
  • Pruthi A, Singh H, Rawath Y, Kaur N. Clinical Significance of Retrograde Inferior Vena Cava and Hepatic Vein Opacification during Contrast Enhanced Tri-Phasic CT Abdomen Acquired as Part of F-18 FDG PET CT Scan – Learning Point For Nuclear Medicine Physicians: A Case Report and Literature Survey. Indian J Nucl Med. 2020 Jul-Sep;35(3):229-231
  • Baidya A, Sachdeva CG, Bhatia P, Pruthi A, Joshi S. Serum galactomannan in histoplasmosis in HIV. Indian J Sex Transm Dis AIDS. 2022; 43: 181-183.

Membership

  • Society of Nuclear Medicine India (SNMI)
  • EANM (European Association of Nuclear Medicine, Austria)
  • ANMPI (Association of Nuclear Medicine Physicians of India)
  • WARMTH (World Association of Radiopharmaceutical and Molecular Therapy)
  • Oncology Forum, Delhi

Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7

Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7

Subscribe Today For Our Healthy Tips Newsletter
Loading